UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises

Medical products maker ​Smith+Nephew posted ‌a 3.1% rise ​in ​first-quarter underlying revenue on ⁠Wednesday, ​helped by ​strong sports medicine and wound ​management ​performance, and kept ‌its ⁠annual outlook unchanged while announcing ​a $500 ​million ⁠share buyback.